Artificial Intelligence is revolutionizing the management of non-small cell lung cancer (NSCLC) by enhancing diagnostics, improving treatment predictions, and personalizing care strategies, leading to better patient outcomes. This involves machine learning algorithms that analyze patient data for tailored therapy recommendations.

Read More:

• 🔗 www.cancernetwork.com